Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|February 2, 1997
Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationM A Gertz, T E Witzig, A A Pineda, et al.
Diseases of the Colon and Rectum|June 1, 1996
Carcinoid tumor of the rectum. DNA ploidy is not a prognostic factorS D Fitzgerald, A P Meagher, P Moniz-Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathiesT E Witzig, N J Gonchoroff, J A Katzmann, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|June 15, 1993
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.
Leukemia & Lymphoma|March 26, 2002
Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphomaY Yoong, P J Kurtin, C Allmer, et al.
American Journal of Hematology|February 1, 1986
T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosisT E Witzig, R L Phyliky, C Y Li, et al.
Leukemia|June 25, 2010
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signalingS Hussain, O Foreman, S L Perkins, et al.
Cytometry|January 1, 1993
Consensus review of the clinical utility of DNA flow cytometry in colorectal cancerK D Bauer, C B Bagwell, W Giaretti, et al.
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|February 2, 1997
Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationM A Gertz, T E Witzig, A A Pineda, et al.
Diseases of the Colon and Rectum|June 1, 1996
Carcinoid tumor of the rectum. DNA ploidy is not a prognostic factorS D Fitzgerald, A P Meagher, P Moniz-Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathiesT E Witzig, N J Gonchoroff, J A Katzmann, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|June 15, 1993
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.
Leukemia & Lymphoma|March 26, 2002
Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphomaY Yoong, P J Kurtin, C Allmer, et al.
American Journal of Hematology|February 1, 1986
T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosisT E Witzig, R L Phyliky, C Y Li, et al.
Leukemia|June 25, 2010
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signalingS Hussain, O Foreman, S L Perkins, et al.
Cytometry|January 1, 1993
Consensus review of the clinical utility of DNA flow cytometry in colorectal cancerK D Bauer, C B Bagwell, W Giaretti, et al.
Pageof 19